Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Nitric oxide donors reduce the invasion ability of ovarian cancer cells in vitro.

Kielbik M, Szulc I, Brzezinska M, Bednarska K, Przygodzka P, Sulowska Z, Nowak M, Klink M.

Anticancer Drugs. 2014 Nov;25(10):1141-51. doi: 10.1097/CAD.0000000000000149.

PMID:
25035962
2.

Either non-homologous ends joining or homologous recombination is required to repair double-strand breaks in the genome of macrophage-internalized Mycobacterium tuberculosis.

Brzostek A, Szulc I, Klink M, Brzezinska M, Sulowska Z, Dziadek J.

PLoS One. 2014 Mar 21;9(3):e92799. doi: 10.1371/journal.pone.0092799.

3.

Nitric oxide donors: spermine/NO and diethylenetriamine/NO induce ovarian cancer cell death and affect STAT3 and AKT signaling proteins.

Kielbik M, Klink M, Brzezinska M, Szulc I, Sulowska Z.

Nitric Oxide. 2013 Nov 30;35:93-109. doi: 10.1016/j.niox.2013.09.001.

PMID:
24055735
4.

Cholesterol oxidase is indispensable in the pathogenesis of Mycobacterium tuberculosis.

Klink M, Brzezinska M, Szulc I, Brzostek A, Kielbik M, Sulowska Z, Dziadek J.

PLoS One. 2013 Sep 9;8(9):e73333. doi: 10.1371/journal.pone.0073333.

5.

The role of 3-ketosteroid 1(2)-dehydrogenase in the pathogenicity of Mycobacterium tuberculosis.

Brzezinska M, Szulc I, Brzostek A, Klink M, Kielbik M, Sulowska Z, Pawelczyk J, Dziadek J.

BMC Microbiol. 2013 Feb 20;13:43. doi: 10.1186/1471-2180-13-43.

Supplemental Content

Support Center